Charles River Raises 2026 Non-GAAP EPS Outlook to $11.35-$11.55
Photo: TokenPost
Charles River Laboratories International, Inc. raised its 2026 non-GAAP earnings-per-share outlook to $11.35-$11.55 after third-quarter non-GAAP EPS came in above its prior outlook, while lifting its organic revenue-growth forecast to at least 1.5%. Higher operating income and a lower tax rate contributed to the increase. The DSA book-to-bill ratio was 1.09x for a fourth consecutive quarter above 1x. Charles River’s long-term target is 5% to 7% DSA organic revenue growth. The company expects gradual DSA growth, while noting that pricing power has not returned and that study timing, mix and resource availability affect visibility.
Source: TokenPost
